Strengthening the R&D Structure and Collaboration with Academic Institutions
First written in FY2017. 8 of 9 entries say "Advanced", first in FY2018. Latest entry: FY2025.
28 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「On 1 April 2025, the Group doubled the research space at the Tokyo Research Institute, its futuristic communications laboratory.」
The Group doubled the research space at the Tokyo Research Institute, specifically strengthening the R&D environment. The R&D division also continues to create innovation in cosmetics, quasi-drugs, pharmaceuticals and food products. - FY2024AdvancedAnnual report
「The Group’s R&D Division of ㈱ノエビア is responsible for developing new products and aims to create innovation in cosmetics, quasi-drugs, pharmaceuticals and food products. The Shiga Research Institute is adjacent to the Shiga Plant, which produces cosmetics, and is accelerating product development. The intellectual property and regulatory affairs application divisions were integrated into the R&D division, strengthening product development.」
The integration of the intellectual property and regulatory affairs application divisions into R&D, acceleration of product development by the Shiga Research Institute, and use of the plant research center have been made concrete. - FY2023AdvancedAnnual report
「In support of the establishment of the sponsored research program in osteoimmunology at the Graduate School of Medicine, the University of Tokyo, the Group has continued its donations since 2016, and the program entered its third phase in 2022. Along with applying advanced immunology research findings, the Group is also focusing on disseminating information.」
The sponsored research program in osteoimmunology has entered its third phase, with continued application of research findings and dissemination of information. Specific research findings on plants, skin barrier function and anti-aging are also taking shape. - FY2022AdvancedAnnual report
「Based on research findings from the sponsored research program in osteoimmunology established at the Graduate School of Medicine, the University of Tokyo, the Group found that RANKL, a key protein in the new field of osteoimmunology, is deeply involved in maintaining skin homeostasis and applied the findings to cosmetics. The Tokyo Research Institute has strengthened its functions and expanded its site area.」
The Group has applied research findings on RANKL to cosmetics and is also strengthening the functions of and expanding the site area of the Tokyo Research Institute. - FY2021AdvancedAnnual report
「Based on research findings from the sponsored research program in osteoimmunology established at the Graduate School of Medicine, the University of Tokyo, the Group discovered that RANKL, a key protein in the new field of osteoimmunology, is deeply involved in maintaining skin homeostasis. It is advancing the application of these findings to cosmetics.」
The Group discovered a relationship between RANKL and skin homeostasis through research findings from the sponsored research program and has progressed to the application stage for cosmetics. - FY2020AdvancedAnnual report
「A sponsored research program in osteoimmunology was established at the Graduate School of Medicine, the University of Tokyo, contributing to the development of medicine through basic research in osteoimmunology, a new field of immunology. In the molecular medicine program on the skin-brain connection established at the Department of Pharmacology, Tokyo Medical University, the Group discovered that CLSP suppresses the aging of skin cells and applied the findings to Noevir Neurologic Medicated Serum.」
Research findings from sponsored research programs and joint research have progressed to the stage of application in specific cosmetic products. - FY2019AdvancedAnnual report
「The sponsored research program in osteoimmunology established at the Graduate School of Medicine, the University of Tokyo, has entered its second phase. The program has reported numerous research findings from the new field of osteoimmunology and is contributing to the development of medicine.」
The sponsored research program in osteoimmunology has entered its second phase and progressed to the reporting of research findings. Specific achievements involving Tokyo Medical University, the University of Tokyo and clinical research are also described. - FY2018AdvancedAnnual report
「The Tokyo Research Institute promotes basic research on materials and clinical research on products, expands its research fields by strengthening its expertise and actively collaborating with external institutions, and works to strengthen the R&D structure. A sponsored research program in osteoimmunology was established at the Graduate School of Medicine, the University of Tokyo, contributing to the development of immunology research.」
Specific progress is shown through basic and clinical research at the Tokyo Research Institute, collaboration with external institutions, and the establishment of a sponsored research program at the University of Tokyo Graduate School. - FY2017First statedAnnual report
「The Group’s Comprehensive Research Institute in Shiga Prefecture promotes the development of cosmetics, pharmaceutical products and food products. The Tokyo Research Institute is expanding its research fields through active exchanges with external research institutions and is working to strengthen the R&D structure.」
The Group is expanding its research fields through collaboration among its research centers in Shiga and Tokyo, external research institutions, the University of Tokyo Graduate School and Tokyo Medical University.